Should I buy or sell Dechra Pharmaceuticals stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dechra Pharmaceuticals in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DPH shares. View DPH analyst ratings or view top-rated stocks .

What is Dechra Pharmaceuticals' stock price target for 2024?

2 Wall Street research analysts have issued 12 month price targets for Dechra Pharmaceuticals' shares. Their DPH share price targets range from GBX 4,000 to GBX 4,070. On average, they expect the company's stock price to reach GBX 4,035 in the next twelve months. This suggests a possible upside of 4.4% from the stock's current price. View analysts price targets for DPH or view top-rated stocks among Wall Street analysts .

How have DPH shares performed in 2024?

Dechra Pharmaceuticals' stock was trading at GBX 3,858 at the start of the year. Since then, DPH stock has increased by 0.2% and is now trading at GBX 3,866. View the best growth stocks for 2024 here .

Is Dechra Pharmaceuticals a good dividend stock?

Dechra Pharmaceuticals (LON:DPH) pays an annual dividend of GBX 45 per share and currently has a dividend yield of 1.20%. Read our dividend analysis for DPH .

What other stocks do shareholders of Dechra Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dechra Pharmaceuticals investors own include 32Red (TTR) , 1428686 (SGP.L) (SGP) , JD Sports Fashion (JD) , Ashtead Group (AHT) , Cranswick (CWK) , Drax Group (DRX) , RPC Group (RPC) , Robert Walters (RWA) , SEB (SKP) and Barratt Developments (BDEV) .

How do I buy shares of Dechra Pharmaceuticals?

Shares of DPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:DPH

Dechra Pharmaceuticals (DPH) Share Price, News & Analysis

→ Uncover this 2024 Hidden Gem (From Tips4Traders) (Ad)

Free DPH Stock Alerts

GBX 3,866

0.00 (0.00%)

(As of 01/16/2024)

Compare

Today's Range: 3,866
▼
3,866
50-Day Range: 3,866
▼
3,866
52-Week Range: 2,473.32
▼
4,145.84

Volume: 2.04 million shs
Average Volume: 1.29 million shs
Market Capitalization: £4.40 billion

P/E Ratio: N/A
Dividend Yield: 1.16%
Price Target: GBX 4,035

Stock Analysis Analyst Forecasts Chart Dividend Headlines Insider Trades

Get Dechra Pharmaceuticals alerts:

Ad DTI

Did you know you can now trade Bitcoin in your regular brokerage account?

You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet!

>> Tap here to sign up and join them for the imminent workshop

About Dechra Pharmaceuticals Stock (LON:DPH)

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, internal medicine, and nutrition products supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. It also provides water soluble antibiotics, vaccines, lameness, pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. In addition, the company distributes veterinary pharmaceuticals and equipment; markets pet diets; and develops, regulates, manufactures, and markets crop protection, as well as offers financial services. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

DPH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DPH Stock News Headlines

February 15, 2024 | finance.yahoo.com

Dechra Pharmaceuticals PLC (DPH.L)

February 11, 2024 | benzinga.com

Dechra Pharmaceuticals Stock (OTC:DPHAY) Dividends: History, Yield and Dates

April 19, 2024 | DTI (Ad)

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

January 15, 2024 | finance.yahoo.com

Form 8.3 - Dechra Phartmaceuticals PLC - Amendment

November 29, 2023 | msn.com

UK's Hargreaves says Dechra's Platt to succeed Oppenheimer as chair

November 10, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 09-November-23 Decrease in Traded Position Disclosure

November 9, 2023 | morningstar.com

Dechra Pharmaceuticals PLC DPH

November 2, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 01-November-23 Decrease in Traded Position Disclosure

April 19, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

October 31, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 30-October-23 Decrease in Traded Position Disclosure

October 30, 2023 | finanznachrichten.de

Magnetar Capital Partners LP - Form 8.3 - Dechra Pharmaceuticals plc

October 24, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 23-October-23 Increase in Traded Position Disclosure

October 18, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 17-October-23 Increase in Traded Position Disclosure

October 12, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 28-September-23 Increase in Traded Position Amendment

October 12, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 03-October-23 Decrease in Traded Position Amendment

October 12, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 05-October-23 Dealing Disclosure - Amendment

October 11, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 10-October-23 Decrease in Traded Position Disclosure

October 4, 2023 | proactiveinvestors.com

Private equity ‘vultures’ feast on beleaguered public markets

September 29, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 28-September-23 Dealing Disclosure

September 21, 2023 | marketwatch.com

Dechra Pharmaceuticals falls Thursday, still outperforms market

September 20, 2023 | finance.yahoo.com

Form 8.3 - Dechra Pharmaceuticals plc - Amendment

September 15, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 14-September-23 Dealing Disclosure

August 31, 2023 | markets.businessinsider.com

Back in the Big League: M&S Rejoins the FTSE 100 on Share Price Boost

August 22, 2023 | finance.yahoo.com

Marks & Spencer Set for FTSE 100 Comeback After This Year’s 78% Share Price Rise

August 15, 2023 | marketwatch.com

Dechra Pharmaceuticals remains steady Tuesday, still outperforms market

July 20, 2023 | bloomberg.com

DPH: Carlson Capital, L.P.: Form 8.3 - Dechra Pharmaceuticals plc

July 12, 2023 | finance.yahoo.com

Form 8.3 - DPH LN Equity 11-July-23 Increase in Traded Position

See More Headlines

Receive DPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dechra Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Drug Manufacturers - General
Sub-Industry: N/A
Current Symbol: LON:DPH
CUSIP: N/A
CIK: N/A
Web: www.dechra.com
Phone: +44-1606-814730
Fax: N/A
Employees: 2,457
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: GBX 4,035
High Stock Price Target: GBX 4,070
Low Stock Price Target: GBX 4,000
Potential Upside/Downside: +4.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX (0.25)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 20.41
P/E Growth: 1.42
Net Income: £-27,900,000.00
Net Margins: -3.66%
Pretax Margin: N/A
Return on Equity: -3.92%
Return on Assets: 0.75%

Debt

Debt-to-Equity Ratio: 66.80
Current Ratio: 2.85
Quick Ratio: 1.66

Sales & Book Value

Annual Sales: £761.50 million
Price / Sales: 5.78
Cash Flow: GBX 158.24 per share
Price / Cash Flow: 24.43
Book Value: GBX 663 per share
Price / Book: 5.83

Miscellaneous

Outstanding Shares: 113,910,000
Free Float: N/A
Market Cap: £4.40 billion
Optionable: Not Optionable
Beta: 0.78

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Ian D. Page (Age 63)
CEO, MD & Executive Director
Comp: $848k
Mr. Paul Nicholas Sandland MAAT (Age 45)
FCCA, CFO & Executive Director
Comp: $559k
Mr. Patrick Meeus
Chief Scientific Officer
Mr. Jamie Adams
Chief Information Officer
Ms. Katy Clough
Chief People Officer
Mr. Mike Eldred (Age 54)
President of North America
Ms. Melanie Jane Hall
Company Secretary

Key Competitors

View All Competitors

Insiders

Ian Page
Bought 155 shares on 1/15/2024
Total: £501,735.00 ($3,237.00/share)

View All Insider Transactions

DPH Stock Analysis - Frequently Asked Questions

Should I buy or sell Dechra Pharmaceuticals stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dechra Pharmaceuticals in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DPH shares.
View DPH analyst ratings or view top-rated stocks.
What is Dechra Pharmaceuticals' stock price target for 2024?: 2 Wall Street research analysts have issued 12 month price targets for Dechra Pharmaceuticals' shares. Their DPH share price targets range from GBX 4,000 to GBX 4,070. On average, they expect the company's stock price to reach GBX 4,035 in the next twelve months. This suggests a possible upside of 4.4% from the stock's current price.
View analysts price targets for DPH or view top-rated stocks among Wall Street analysts.
How have DPH shares performed in 2024?: Dechra Pharmaceuticals' stock was trading at GBX 3,858 at the start of the year. Since then, DPH stock has increased by 0.2% and is now trading at GBX 3,866.
View the best growth stocks for 2024 here.
Is Dechra Pharmaceuticals a good dividend stock?: Dechra Pharmaceuticals (LON:DPH) pays an annual dividend of GBX 45 per share and currently has a dividend yield of 1.20%.
Read our dividend analysis for DPH.

What other stocks do shareholders of Dechra Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Dechra Pharmaceuticals investors own include 32Red (TTR), 1428686 (SGP.L) (SGP), JD Sports Fashion (JD), Ashtead Group (AHT), Cranswick (CWK), Drax Group (DRX), RPC Group (RPC), Robert Walters (RWA), SEB (SKP) and Barratt Developments (BDEV).
How do I buy shares of Dechra Pharmaceuticals?: Shares of DPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:DPH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Dechra Pharmaceuticals (DPH) Share Price, News & Analysis

About Dechra Pharmaceuticals Stock (LON:DPH)

DPH Stock Price History

DPH Stock News Headlines

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

DPH Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info